ACID REDUCER (FAMOTIDINE)
- Duodenal ulcer
- Dyspepsia
- Erosive esophagitis
- Gastric ulcer
- Gastroesophageal reflux disease
- Heartburn
- Duodenal ulcer
- Duodenal ulcer due to h. pylori
- Dyspepsia prevention
- Erosive esophagitis
- Gastric hypersecretion with systemic mastocytosis
- Gastric ulcer
- Gastroesophageal reflux disease
- Heartburn
- Heartburn prevention
- Helicobacter pylori gastritis
- Maintenance of healing duodenal ulcer
- Maintenance of healing erosive esophagitis
- Maintenance of healing gastric ulcer
- Multiple endocrine neoplasia
- Pathological gastric acid hypersecretory condition
- Reflux esophagitis
- Zollinger-ellison syndrome
- Zantac Tablet
- Zantac Maximum Strength Tablet
- Zantac 75 Tablet
- Wal-zan 75 Tablet
- Wal-zan 150 Tablet
- Tagamet Hb Tablet
- Ranitidine Tablet
- Pepcid Tablet
- Pepcid Ac Tablet
- Omeprazole Magnesium Capsule,delayed Release
- Heartburn Relief Tablet
- Heartburn Relief (ranitidine) Tablet
- Heartburn Relief (famotidine) Tablet
- Heartburn Relief (cimetidine) Tablet
- Heartburn Prevention Tablet
- Famotidine Tablet
- Cimetidine Tablet
- Acid Reducer (ranitidine) Tablet
- Acid Reducer (omeprazole) Capsule,delayed Release
- Acid Reducer (famotidine) Tablet
- Acid Reducer (cimetidine) Tablet
- Acid Controller Tablet
- Acid Control (ranitidine) Tablet
- By Indication
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Maximum Strength 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
ranitidine 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
ranitidine 300 mg tablet
- 1 tablet (300 mg) by oral route once daily at bedtime
ranitidine 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
40 mg tablet
- 1 tablet (40 mg) by oral route once daily at bedtime
10 mg tablet
- 1 tablet (10 mg) by oral route once daily as needed
20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
20 mg capsule,delayed release
- Dosage information is not available
(cimetidine) 200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
(ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
(ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
Heartburn Relief (ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Heartburn Relief (ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
(famotidine) 10 mg tablet
- 1 tablet (10 mg) by oral route once daily as needed
(famotidine) 20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
(cimetidine) 200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
10 mg tablet
- 1 tablet (10 mg) by oral route once daily as needed
20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
10 mg tablet
- 1 tablet (10 mg) by oral route once daily as needed
20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
40 mg tablet
- 1 tablet (40 mg) by oral route once daily at bedtime
200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
300 mg tablet
- 1 tablet (300 mg) by oral route 4 times per day with meals and at bedtime
400 mg tablet
- 1 tablet (400 mg) by oral route 2 times per day in the morning and at bedtime
800 mg tablet
- 1 tablet (800 mg) by oral route once daily at bedtime
(ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
(ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
Acid Reducer (ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Acid Reducer (ranitidine) 75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
(omeprazole) 20 mg capsule,delayed release
- Dosage information is not available
(famotidine) 10 mg tablet
- 1 tablet (10 mg) by oral route once daily as needed
(famotidine) 20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
(cimetidine) 200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
200 mg tablet
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
10 mg tablet
- 1 tablet (10 mg) by oral route once daily as needed
20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
ler 10 mg tablet
- 1 tablet (10 mg) by oral route once daily as needed
ler 20 mg tablet
- 1 tablet (20 mg) by oral route 2 times per day
(ranitidine) 150 mg tablet
- 1 tablet (150 mg) by oral route 2 times per day
Duodenal ulcer
- 1 tablet (20 mg) by oral route 2 times per day
- 1 tablet (20 mg) by oral route every 12 hours
- 2 tablets (40 mg) by oral route once daily at bedtime
- 1 tablet (150 mg) by oral route 2 times per day
- 2 tablets (300 mg) by oral route once daily at bedtime
Dyspepsia
- 1 tablet (10 mg) by oral route 2 times per day as needed
- 1 tablet (10 mg) by oral route once daily as needed
- 2 tablets (20 mg) by oral route every 12 hours
- 2 tablets (150 mg) by oral route every 12 hours
- 1 tablet (200 mg) by oral route once daily 30 minutes before meals
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
Dyspepsia prevention
- 1 tablet (10 mg) by oral route 2 times per day as needed
- 1 tablet (10 mg) by oral route once daily as needed
- 2 tablets (20 mg) by oral route every 12 hours
Erosive esophagitis
- 1 tablet (20 mg) by oral route 2 times per day
- 2 tablets (40 mg) by oral route 2 times per day
- 1 tablet (150 mg) by oral route 4 times per day
Gastric hypersecretion with systemic mastocytosis
- 1 tablet (20 mg) by oral route every 6 hours
- 2 tablets (40 mg) by oral route every 6 hours
- 1 tablet (150 mg) by oral route 2 times per day
Gastric ulcer
- 2 tablets (40 mg) by oral route once daily at bedtime
- 1 tablet (150 mg) by oral route 2 times per day
Gastroesophageal reflux disease
- 1 tablet (20 mg) by oral route 2 times per day
- 1 tablet (20 mg) by oral route every 12 hours
- 2 tablets (40 mg) by oral route once daily at bedtime
- 1 tablet (150 mg) by oral route 2 times per day
Heartburn
- 1 tablet (10 mg) by oral route 2 times per day as needed
- 1 tablet (10 mg) by oral route once daily as needed
- 1 tablet (75 mg) by oral route once daily with glass of water
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
- 1 tablet (150 mg) by oral route 4 times per day
- 1 tablet (150 mg) by oral route 2 times per day
- 1 tablet (200 mg) by oral route once daily 30 minutes before meals
- 1 tablet (200 mg) by oral route 2 times per day 30 minutes before meals
Heartburn prevention
- 1 tablet (10 mg) by oral route 2 times per day as needed
- 1 tablet (10 mg) by oral route once daily as needed
Maintenance of healing duodenal ulcer
- 1 tablet (20 mg) by oral route once daily at bedtime
- 1 tablet (150 mg) by oral route once daily at bedtime
Maintenance of healing erosive esophagitis
- 1 tablet (150 mg) by oral route 2 times per day
Maintenance of healing gastric ulcer
- 1 tablet (150 mg) by oral route once daily at bedtime
Multiple endocrine neoplasia
- 1 tablet (20 mg) by oral route every 6 hours
- 2 tablets (40 mg) by oral route every 6 hours
- 1 tablet (150 mg) by oral route 2 times per day
Pathological gastric acid hypersecretory condition
- 1 tablet (20 mg) by oral route every 6 hours
- 2 tablets (40 mg) by oral route every 6 hours
- 1 tablet (150 mg) by oral route 2 times per day
Reflux esophagitis
- 1 tablet (20 mg) by oral route 2 times per day
- 2 tablets (40 mg) by oral route 2 times per day
Upper GI bleed
- 1 tablet (20 mg) by oral route 2 times per day
- 1 tablet (20 mg) by oral route every 12 hours
Zollinger-ellison syndrome
- 1 tablet (20 mg) by oral route every 6 hours
- 2 tablets (40 mg) by oral route every 6 hours
- 1 tablet (150 mg) by oral route 2 times per day
- atazanavir
- Complera
- dofetilide
- Edurant
- Ellence
- emtricitab-rilpivirine-tenofov
- epirubicin
- nelfinavir
- Reyataz
- rilpivirine
- Tikosyn
- Viracept
Contraindicated
- acetaminophen-caff-pyrilamine
- acetaminophen-caffeine
- Added Strength Headache Relief
- Added Strength Pain Reliever
- Alagesic Lq
- Alertness Aid
- aminophylline
- Anacin
- Anacin Maximum Strength
- Analgesic
- ASA-acetaminophen-caff-buffers
- ASA-acetaminophen-salicyl-caff
- Ascomp With Codeine
- aspirin-acetaminophen-caffeine
- aspirin-caffeine
- Awake
- Back & Body Pain Reliever
- Back Pain-off
- Bayer Aspirin (with Caffeine)
- Bayer Back & Body
- Bc
- Bc Arthritis
- Bicnu
- Bosulif
- bosutinib
- Burn Calories
- Butalbital Compound W/codeine
- Butalbital Compound-codeine
- butalbital-acetaminop-caf-cod
- butalbital-acetaminophen-caff
- butalbital-aspirin-caffeine
- Cafcit
- Cafergot
- caffeine
- caffeine citrated
- caffeine-choline-AA#11-hrb#130
- caffeine-sodium benzoate
- Capacet
- carmustine
- carmustine in polifeprosan
- Cellcept
- Cellcept Intravenous
- citalopram
- clobazam
- clopidogrel
- codeine-butalbital-ASA-caff
- Coumadin
- Daily Energy
- dasatinib
- Dietex Forte
- dihydrocodeine-aspirin-caff
- Elixophyllin
- ergotamine-caffeine
- erlotinib
- Esgic
- Excedrin Extra Strength
- Excedrin Migraine
- Excedrin Tension Headache
- Fioricet
- Fioricet With Codeine
- Fiorinal
- Fiorinal-codeine #3
- Gliadel Wafer
- Goody's Extra Strength
- Goody's Migraine Relief
- guanfacine
- Guarana
- guarana-calcium-amino acid cmb
- guarana-calcium-phosphorus
- guarana-Cr-citaurantium-hrb109
- guarana-Cr-gr tea-yrb mat-hb39
- Headache Formula
- Headache Formula Added Str
- Headache Relief
- Hypertensa
- ibrutinib
- Imbruvica
- Intuniv Er
- isomethepten-caf-acetaminophen
- itraconazole
- Jantoven
- ketoconazole
- Levacet
- Margesic
- Menstrual Complete
- Menstrual Relief
- methotrexate sodium
- methotrexate sodium (PF)
- Mg salicylat-acetaminophen-caf
- Midol Complete
- Midol Max St Menstrual
- Migergot
- Migraine Formula
- Migraine Pain Reliever
- Migraine Relief
- mv,Ca,Fe,min-FA-guarana-caff
- mv,Ca,Fe,min-FA-hrb cmplx145
- mv,Ca,Fe,min-FA-hrb cmplx146
- mv,ca,min-iron-FA-EGCG-caffein
- mv,Ca,min-iron-FA-guarana-caff
- mycophenolate mofetil
- mycophenolate mofetil HCl
- nilotinib
- No Doz
- Noxafil
- Olysio
- One Daily
- One Daily Diet Support
- One Daily Energy
- One Daily Healthy Weight
- One Daily Women's Metabolism
- One-a-day Weightsmart
- One-a-day Women's Active
- Onfi
- Onmel
- Orap
- Orphenadrine Compound Forte
- Orphenadrine Compound-ds
- orphenadrine-ASA-caffeine
- Pain Relief
- Pain Relief Extra Strength
- Pain Reliever
- Pain Reliever Extra Strength
- Pain Reliever Plus
- Pain-off
- Pamprin Max
- pentoxifylline
- pimozide
- Plavix
- posaconazole
- Prodrin
- resve-chrom-grn tea-EGCG-dig#3
- Resveratrol Diet
- simeprevir
- Soltamox
- Sporanox
- Sporanox Pulsepak
- Sprycel
- Stay Awake
- Stay Awake Maximum Strength
- Super Pain Relief
- Synalgos-dc
- tamoxifen
- Tarceva
- Tasigna
- Tenex
- Tension Headache
- Tension Headache Pain Reliever
- Tension Headache Relief
- Theo-24
- Theochron
- theophylline
- theophylline in dextrose 5 %
- tizanidine
- Ultra Energy
- Vanquish
- Vivarin
- warfarin
- Women's Active
- Zanaflex
- Zebutal
Severe
Moderate
- Abstral
- acetaminophen-codeine
- Actiq
- Actoplus Met
- Actoplus Met Xr
- Adalat Cc
- Adderall
- Adderall Xr
- Afeditab Cr
- Alfenta
- alfentanil
- alogliptin-metformin
- alprazolam
- Alprazolam Intensol
- amitriptyline
- amitriptyline-chlordiazepoxide
- amoxapine
- Amphetamine Salt Combo
- Amrix
- Anafranil
- Anti-diarrhea
- Anti-diarrheal (lope)-anti-gas
- Anti-diarrheal (loperamide)
- Astagraf Xl
- Astramorph-pf
- avanafil
- Avinza
- belladonna alkaloids-opium
- Belladonna-opium
- bromphen-pseudoephed-codeine
- brompheniramine-PE-codeine
- Buprenex
- buprenorphine
- buprenorphine-naloxone
- butorphanol tartrate
- Butrans
- Capcof
- Capital With Codeine
- carbamazepine
- Carbatrol
- Cardene Iv
- Cardene Iv In Dextrose
- Cardene Iv In Sodium Chloride
- Cardene Sr
- Cardizem
- Cardizem Cd
- Cardizem La
- carisoprodol-ASA-codeine
- Cartia Xt
- Ceftin
- cefuroxime axetil
- Celexa
- Cerebyx
- Cheratussin Ac
- Cheratussin Dac
- chlorcyclizine-codeine
- chlordiazepoxide HCl
- chlordiazepoxide-clidinium
- chlorphen-pseudoephed-codeine
- chlorpheniramine-codeine
- chlorpheniramine-hydrocodone
- chlorpheniramine-PE-codeine
- cilostazol
- clomipramine
- clonazepam
- clorazepate dipotassium
- clrcycliz-pseudoephed-codeine
- codeine sulfate
- codeine-guaifenesin
- codeine-pyrilamine
- cpm-pseudoephed-hydrocodone
- cyclobenzaprine
- cyclobenzaprine with msm
- Demerol
- Demerol (pf)
- Depodur (pf)
- desipramine
- dexbrompheniramine-PSE-codeine
- dexchlorphen-phenyleph-codeine
- Dexedrine Spansule
- dextroamphetamine
- dextroamphetamine-amphetamine
- dextromethorphan-quinidine
- Diamode
- Diastat
- Diastat Acudial
- diazepam
- Diazepam Intensol
- Dilacor Xr
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Dilaudid
- Dilaudid (pf)
- Dilaudid-hp (pf)
- Dilt-xr
- diltiazem HCl
- Diskets
- Dolophine
- Doral
- doxepin
- Duragesic
- Duramorph (pf)
- Dutoprol
- Endocet
- Endodan
- Epitol
- Equetro
- escitalopram oxalate
- estazolam
- ethotoin
- Exalgo Er
- Ez Use Joint-tunnel-trigger
- felodipine
- fentanyl
- fentanyl citrate
- fentanyl citrate (PF)
- Fentora
- flurazepam
- Fortamet
- fosphenytoin
- glipizide-metformin
- Glucophage
- Glucophage Xr
- Glucovance
- Glumetza
- glyburide-metformin
- Guaiatussin Ac
- Guaifenesin Ac
- Guaifenesin Dac
- Guiatuss Ac
- Hecoria
- Hycet
- hydrocodone bitartrate
- Hydrocodone Compound
- hydrocodone-acetaminophen
- hydrocodone-homatropine
- hydrocodone-ibuprofen
- Hydromet
- hydromorphone
- hydromorphone (PF)
- Ibudone
- ibuprofen-oxycodone
- imipramine HCl
- imipramine pamoate
- Imodium Multi-symptom Relief
- Inderal La
- Inderal Xl
- Innopran Xl
- Iophen C-nr
- Isentress
- isradipine
- Janumet
- Janumet Xr
- Jentadueto
- Juxtapid
- Kadian
- Kazano
- Klonopin
- Kombiglyze Xr
- Lazanda
- Lexapro
- Librax (with Clidinium)
- lidocaine (PF)
- lidocaine in D5W (PF)
- linagliptin-metformin
- Lo-peramide
- lomitapide
- loperamide
- loperamide-simethicone
- Lopressor
- Lopressor Hct
- Lortab Elixir
- Lortuss Ex
- M-clear Wc
- M-end Max D
- M-end Pe
- Mar-cof Bp
- Mar-cof Cg
- Matzim La
- meperidine
- meperidine (PF)
- Meperitab
- metformin
- methadone
- Methadone Intensol
- Methadose
- Methotrexate (anti-rheumatic)
- metoprolol su-hydrochlorothiaz
- metoprolol succinate
- metoprolol ta-hydrochlorothiaz
- metoprolol tartrate
- midazolam
- midazolam (PF)
- morphine
- morphine (PF)
- morphine concentrate
- morphine liposomal (PF)
- Ms Contin
- nalbuphine
- nicardipine
- nicardipine in dextrose,iso-os
- nicardipine in NaCl (iso-os)
- Nifedical Xl
- nifedipine
- Niravam
- nisoldipine
- Norco
- Norpramin
- nortriptyline
- Nuedexta
- Opana
- Opana Er
- opium tincture
- Oxecta
- oxycodone
- oxycodone-acetaminophen
- oxycodone-aspirin
- Oxycontin
- oxymorphone
- Pamelor
- paregoric
- Peganone
- pentazocine lactate
- pentazocine-naloxone
- Percocet
- Percodan
- perphenazine-amitriptyline
- Phenylhistine
- Phenylhistine Dh
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- pioglitazone-metformin
- Pletal
- Poly-tussin
- Poly-tussin Ac
- Poly-tussin D
- Prandimet
- Primlev
- Pro-clear Ac
- Pro-clear Caps
- Pro-red Ac (w/ Dexchlorphenir)
- procainamide
- Procardia
- Procardia Xl
- Procentra
- Prograf
- Promethazine Vc-codeine
- promethazine-codeine
- promethazine-phenyleph-codeine
- propranolol
- propranolol-hydrochlorothiazid
- protriptyline
- Prudoxin
- pseudoephedrine-codeine-GG
- pseudoephedrine-hydrocodone
- quazepam
- quinidine gluconate
- quinidine sulfate
- raltegravir
- Relcof C
- remifentanil
- repaglinide-metformin
- Reprexain
- Rezira
- Rheumatrex
- Riomet
- rivaroxaban
- Roxicet
- Rydex
- saxagliptin-metformin
- Silenor
- sitagliptin-metformin
- Sonata
- Statuss Green (codeine)
- Stendra
- Sublimaze (pf)
- Suboxone
- Subsys
- Sufenta
- sufentanil citrate
- Sular
- Surmontil
- Tabradol
- tacrolimus
- Talwin
- Taztia Xt
- Tegretol
- Tegretol Xr
- Tiazac
- Tofranil
- Tofranil-pm
- Toprol Xl
- Tranxene T-tab
- Trexall
- triamcinolone-lidocaine
- triazolam
- trimipramine
- Trymine Cg
- Tusnel C
- Tussicaps
- Tussigon
- Tussionex Pennkinetic Er
- Tylenol-codeine #3
- Tylenol-codeine #4
- Ultiva
- Ultra A-d
- Valium
- Vfend
- Vfend Iv
- Vicodin
- Vicodin Es
- Vicodin Hp
- Vicoprofen
- Virtussin Ac
- Vituz
- Vivactil
- voriconazole
- Xanax
- Xanax Xr
- Xarelto
- Xartemis Xr
- Xodol 10/300
- Xodol 5/300
- Xodol 7.5/300
- Xylocaine (cardiac) (pf)
- Z-tuss Ac
- Z-tuss E
- zaleplon
- Zamicet
- Zenzedi
- Zodryl Ac 25
- Zodryl Ac 30
- Zodryl Ac 35
- Zodryl Ac 40
- Zodryl Ac 50
- Zodryl Ac 60
- Zodryl Ac 80
- Zodryl Dac 25
- Zodryl Dac 30
- Zodryl Dac 35
- Zodryl Dac 40
- Zodryl Dac 50
- Zodryl Dac 60
- Zodryl Dac 80
- Zodryl Dec 25
- Zodryl Dec 30
- Zodryl Dec 35
- Zodryl Dec 40
- Zodryl Dec 50
- Zodryl Dec 60
- Zodryl Dec 80
- Zohydro Er
- zolmitriptan
- Zomig
- Zonalon
- Zubsolv
- Zutripro
- None
Contraindicated
- Chronic kidney disease stage 3A (moderate) GFR 45-59
- Chronic kidney disease stage 3B (moderate) GFR 30-44
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Clostridium difficile infection
- Gastric cancer
- Interstitial nephritis
- Porphyria
- Subacute cutaneous lupus erythematosus
- Systemic lupus erythematosus
Severe
Moderate
- CYp2c19 poor metabolizer
- Disease of liver
- Fracture
- Gastric cancer
- Hypomagnesemia
- Kidney disease with likely reduction in GFR
- Kidney disease with reduction in GFR
- Osteoporosis
- Vitamin b12 deficiency
ACID REDUCER (FAMOTIDINE)
- Duodenal ulcer
- Dyspepsia
- Erosive esophagitis
- Gastric ulcer
- Gastroesophageal reflux disease
- Heartburn
- Duodenal ulcer
- Duodenal ulcer due to h. pylori
- Dyspepsia prevention
- Erosive esophagitis
- Gastric hypersecretion with systemic mastocytosis
- Gastric ulcer
- Gastroesophageal reflux disease
- Heartburn
- Heartburn prevention
- Helicobacter pylori gastritis
- Maintenance of healing duodenal ulcer
- Maintenance of healing erosive esophagitis
- Maintenance of healing gastric ulcer
- Multiple endocrine neoplasia
- Pathological gastric acid hypersecretory condition
- Reflux esophagitis
- Zollinger-ellison syndrome
- None
- Acute abdominal pain
- Constipation
- Diarrhea
- Dizziness
- Flatulence
- Headache disorder
- Vomiting
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Back pain
- Chest pain
- Constipation
- Cough
- Diarrhea
- Dizziness
- Drowsy
- Fever
- General weakness
- Headache disorder
- Nausea
- Pruritus of skin
- Skin rash
- Upper respiratory infection
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute confusion
- Acute pancreatitis
- Agitation
- Agranulocytosis
- Anaphylaxis
- Anemia
- Angioedema
- Anterior ischemic optic neuropathy
- Atrioventricular block
- Atrophic gastritis
- Blurred vision
- Bradycardia
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- Cholestatic hepatitis
- Clostridium difficile infection
- Depression
- Dyspnea
- Erythema multiforme
- Esophageal candidiasis
- Exfoliative dermatitis
- Extrasystoles
- Fever
- Fracture
- Hallucinations
- Hematuria
- Hemolytic anemia
- Hepatic failure
- Hepatitis
- Hyperbilirubinemia
- Hypersensitivity drug reaction
- Hypoglycemic disorder
- Hyponatremia
- Hypotension
- Increased alanine transaminase
- Increased aspartate transaminase
- Interstitial nephritis
- Interstitial pneumonitis
- Jaundice
- Leukocytosis
- Leukopenia
- Malaise
- Neutropenic disorder
- Obstructive hyperbilirubinemia
- Optic neuritis
- Pancreatitis
- Pancytopenia
- Pneumonia
- Proteinuria
- Psychiatric disorder
- Rhabdomyolysis
- Seizure disorder
- Skin rash
- Stevens-johnson syndrome
- Subacute cutaneous lupus erythematosus
- Systemic lupus erythematosus
- Tachycardia
- Thrombocytopenic disorder
- Toxic epidermal necrolysis
- Urticaria
- Vasculitis
- Ventricular premature beats
Less Severe
- Abdominal distension
- Abnormal sexual function
- Acne vulgaris
- Acute abdominal pain
- Acute confusion
- Agitation
- Allergic conjunctivitis
- Alopecia
- Anorexia
- Arthralgias
- Benign fundic gland polyposis of stomach
- Blurred vision
- Cramps
- Delirium
- Diplopia
- Discolored feces
- Drowsy
- Dry eye
- Dry skin
- Dysgeusia
- Epistaxis
- Erectile dysfunction
- Facial edema
- Fatigue
- Fever
- Flushing
- General weakness
- Glycosuria
- Gynecomastia
- Hallucinations
- Hyperhidrosis
- Hypertension
- Hypomagnesemia
- Insomnia
- Irritable bowel syndrome
- Leg pain
- Lethargy
- Malaise
- Mastalgia
- Muscle weakness
- Myalgias
- Nausea
- Ocular irritation
- Pain
- Palpitations
- Paresthesia
- Peripheral edema
- Petechiae
- Pruritus of skin
- Purpura
- Skin inflammation
- Skin photosensitivity
- Skin rash
- Sleep disorder
- Sore throat
- Stomatitis
- Tachycardia
- Testicular pain
- Tinnitus
- Tremor
- Urinary retention
- Urinary tract infection
- Vertigo
- Vitamin b12 deficiency
- Vomiting
- Weight gain
- Xerostomia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Cimetidine
Limited pediatric data. Manufacturer does not recommend age < 16 years.
Safety and efficacy not established age less than 1 year.
- 1 Day – 16 Years
- Limited pediatric data. Manufacturer does not recommend age < 16 years.
- 1 Day – 364 Days
- Limited pediatric data. Manufacturer does not recommend age < 16 years.
Omeprazole (Oral)
Limited pediatric data. Manufacturer does not recommend age < 16 years.
Safety and efficacy not established age less than 1 year.
- 1 Day – 16 Years
- Safety and efficacy not established age less than 1 year.
- 1 Day – 364 Days
- Safety and efficacy not established age less than 1 year.
Cimetidine
- Severity Level:
B
- Additional Notes:
Famotidine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Omeprazole
- Severity Level:
2
- Additional Notes: Limited data sug no increased risk for dev tox after 1st trim
Ranitidine
- Severity Level:
B
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Cimetidine
Insufficient data available; limited data suggest amount excreted is minimal
Limited data suggest low amounts excreted, with no resulting effect on infant
Insufficient data available; low levels excreted into breast milk
Low amounts excreted not likely to result in infant adv effects
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Insufficient data available; limited data suggest amount excreted is minimal |
Famotidine
Insufficient data available; limited data suggest amount excreted is minimal
Limited data suggest low amounts excreted, with no resulting effect on infant
Insufficient data available; low levels excreted into breast milk
Low amounts excreted not likely to result in infant adv effects
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest low amounts excreted, with no resulting effect on infant |
Omeprazole
Insufficient data available; limited data suggest amount excreted is minimal
Limited data suggest low amounts excreted, with no resulting effect on infant
Insufficient data available; low levels excreted into breast milk
Low amounts excreted not likely to result in infant adv effects
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Insufficient data available; low levels excreted into breast milk |
Ranitidine
Insufficient data available; limited data suggest amount excreted is minimal
Limited data suggest low amounts excreted, with no resulting effect on infant
Insufficient data available; low levels excreted into breast milk
Low amounts excreted not likely to result in infant adv effects
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | Low amounts excreted not likely to result in infant adv effects |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Cimetidine
Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Renal impairment may increase risk for confusion in elderly. Avoid or reduce dose for CrCl < 50 mL/min. Hepatic-Hepatic impairment may increase risk for confusion.
Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Dose adjustment may be required for CrCL<50 mL/min. to minimize CNS effects (e.g., mental status changes).
General-Prolonged use may dec absorption of Vitamin B-12. Avoid for >8 weeks duration unless for high risk patients (eg. oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett's esophagitis, pathologic hypersecretory condition, or demonstrated need for maint treatment. Musculoskeletal-Inc risk of fracture with high dose or use >1 year. Gastrointestinal-Long term use may be assoc w/ C. difficile or GI malignancy. Pulmonary-Long term use may be assoc w/pneumonia.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | Y | N | Y | N | N |
BEERS: Y HEDIS: N STOPP: N
Famotidine
Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Renal impairment may increase risk for confusion in elderly. Avoid or reduce dose for CrCl < 50 mL/min. Hepatic-Hepatic impairment may increase risk for confusion.
Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Dose adjustment may be required for CrCL<50 mL/min. to minimize CNS effects (e.g., mental status changes).
General-Prolonged use may dec absorption of Vitamin B-12. Avoid for >8 weeks duration unless for high risk patients (eg. oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett's esophagitis, pathologic hypersecretory condition, or demonstrated need for maint treatment. Musculoskeletal-Inc risk of fracture with high dose or use >1 year. Gastrointestinal-Long term use may be assoc w/ C. difficile or GI malignancy. Pulmonary-Long term use may be assoc w/pneumonia.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | N | N | Y | N | N |
BEERS: Y HEDIS: N STOPP: N
Omeprazole
Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Renal impairment may increase risk for confusion in elderly. Avoid or reduce dose for CrCl < 50 mL/min. Hepatic-Hepatic impairment may increase risk for confusion.
Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Dose adjustment may be required for CrCL<50 mL/min. to minimize CNS effects (e.g., mental status changes).
General-Prolonged use may dec absorption of Vitamin B-12. Avoid for >8 weeks duration unless for high risk patients (eg. oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett's esophagitis, pathologic hypersecretory condition, or demonstrated need for maint treatment. Musculoskeletal-Inc risk of fracture with high dose or use >1 year. Gastrointestinal-Long term use may be assoc w/ C. difficile or GI malignancy. Pulmonary-Long term use may be assoc w/pneumonia.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | N | N | Y | N |
BEERS: Y HEDIS: N STOPP: Y
No Known Risk
None
- None
Duodenal ulcer | |
K26 | Duodenal ulcer |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.1 | Acute duodenal ulcer with perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
Duodenal ulcer due to h. pylori | |
B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
Dyspepsia | |
K30 | Functional dyspepsia |
Dyspepsia prevention | |
K30 | Functional dyspepsia |
Erosive esophagitis | |
K22.1 | Ulcer of esophagus |
K22.10 | Ulcer of esophagus without bleeding |
K22.11 | Ulcer of esophagus with bleeding |
Gastric hypersecretion with systemic mastocytosis | |
C96.21 | Aggressive systemic mastocytosis |
D47.02 | Systemic mastocytosis |
K31.89 | Other diseases of stomach and duodenum |
Gastric ulcer | |
K25 | Gastric ulcer |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.1 | Acute gastric ulcer with perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
Gastroesophageal reflux disease | |
K21 | Gastro-esophageal reflux disease |
K21.0 | Gastro-esophageal reflux disease with esophagitis |
K21.9 | Gastro-esophageal reflux disease without esophagitis |
Heartburn | |
R12 | Heartburn |
Helicobacter pylori gastritis | |
B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
Maintenance of healing duodenal ulcer | |
K26 | Duodenal ulcer |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.1 | Acute duodenal ulcer with perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
Maintenance of healing erosive esophagitis | |
K22.1 | Ulcer of esophagus |
K22.10 | Ulcer of esophagus without bleeding |
K22.11 | Ulcer of esophagus with bleeding |
Maintenance of healing gastric ulcer | |
K25 | Gastric ulcer |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.1 | Acute gastric ulcer with perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K27 | Peptic ulcer, site unspecified |
K27.0 | Acute peptic ulcer, site unspecified, with hemorrhage |
K27.1 | Acute peptic ulcer, site unspecified, with perforation |
K27.2 | Acute peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.3 | Acute peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.4 | Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage |
K27.5 | Chronic or unspecified peptic ulcer, site unspecified, with perforation |
K27.6 | Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.7 | Chronic peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.9 | Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation |
K28 | Gastrojejunal ulcer |
K28.0 | Acute gastrojejunal ulcer with hemorrhage |
K28.1 | Acute gastrojejunal ulcer with perforation |
K28.2 | Acute gastrojejunal ulcer with both hemorrhage and perforation |
K28.3 | Acute gastrojejunal ulcer without hemorrhage or perforation |
K28.4 | Chronic or unspecified gastrojejunal ulcer with hemorrhage |
K28.5 | Chronic or unspecified gastrojejunal ulcer with perforation |
K28.6 | Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation |
K28.7 | Chronic gastrojejunal ulcer without hemorrhage or perforation |
K28.9 | Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
P78.82 | Peptic ulcer of newborn |
Multiple endocrine neoplasia | |
E31.2 | Multiple endocrine neoplasia [MEn] syndromes |
E31.20 | Multiple endocrine neoplasia [MEn] syndrome, unspecified |
E31.21 | Multiple endocrine neoplasia [MEn] type I |
E31.22 | Multiple endocrine neoplasia [MEn] type IIA |
E31.23 | Multiple endocrine neoplasia [MEn] type IIB |
Pathological gastric acid hypersecretory condition | |
K31.89 | Other diseases of stomach and duodenum |
Reflux esophagitis | |
K21.0 | Gastro-esophageal reflux disease with esophagitis |
Zollinger-ellison syndrome | |
E16.4 | Increased secretion of gastrin |
0-9 | A-Z |
---|---|
B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
C96.21 | Aggressive systemic mastocytosis |
D47.02 | Systemic mastocytosis |
E16.4 | Increased secretion of gastrin |
E31.2 | Multiple endocrine neoplasia [MEn] syndromes |
E31.20 | Multiple endocrine neoplasia [MEn] syndrome, unspecified |
E31.21 | Multiple endocrine neoplasia [MEn] type I |
E31.22 | Multiple endocrine neoplasia [MEn] type IIA |
E31.23 | Multiple endocrine neoplasia [MEn] type IIB |
K21 | Gastro-esophageal reflux disease |
K21.0 | Gastro-esophageal reflux disease with esophagitis |
K21.0 | Gastro-esophageal reflux disease with esophagitis |
K21.9 | Gastro-esophageal reflux disease without esophagitis |
K22.1 | Ulcer of esophagus |
K22.1 | Ulcer of esophagus |
K22.10 | Ulcer of esophagus without bleeding |
K22.10 | Ulcer of esophagus without bleeding |
K22.11 | Ulcer of esophagus with bleeding |
K22.11 | Ulcer of esophagus with bleeding |
K25 | Gastric ulcer |
K25 | Gastric ulcer |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.0 | Acute gastric ulcer with hemorrhage |
K25.1 | Acute gastric ulcer with perforation |
K25.1 | Acute gastric ulcer with perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.3 | Acute gastric ulcer without hemorrhage or perforation |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.5 | Chronic or unspecified gastric ulcer with perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K26 | Duodenal ulcer |
K26 | Duodenal ulcer |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.0 | Acute duodenal ulcer with hemorrhage |
K26.1 | Acute duodenal ulcer with perforation |
K26.1 | Acute duodenal ulcer with perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.5 | Chronic or unspecified duodenal ulcer with perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K27 | Peptic ulcer, site unspecified |
K27.0 | Acute peptic ulcer, site unspecified, with hemorrhage |
K27.1 | Acute peptic ulcer, site unspecified, with perforation |
K27.2 | Acute peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.3 | Acute peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.4 | Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage |
K27.5 | Chronic or unspecified peptic ulcer, site unspecified, with perforation |
K27.6 | Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation |
K27.7 | Chronic peptic ulcer, site unspecified, without hemorrhage or perforation |
K27.9 | Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation |
K28 | Gastrojejunal ulcer |
K28.0 | Acute gastrojejunal ulcer with hemorrhage |
K28.1 | Acute gastrojejunal ulcer with perforation |
K28.2 | Acute gastrojejunal ulcer with both hemorrhage and perforation |
K28.3 | Acute gastrojejunal ulcer without hemorrhage or perforation |
K28.4 | Chronic or unspecified gastrojejunal ulcer with hemorrhage |
K28.5 | Chronic or unspecified gastrojejunal ulcer with perforation |
K28.6 | Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation |
K28.7 | Chronic gastrojejunal ulcer without hemorrhage or perforation |
K28.9 | Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
K30 | Functional dyspepsia |
K30 | Functional dyspepsia |
K31.89 | Other diseases of stomach and duodenum |
K31.89 | Other diseases of stomach and duodenum |
P78.82 | Peptic ulcer of newborn |
R12 | Heartburn |